Organogenesis Holdings Inc. to Present at the 9th Annual SVB Leerink Global Healthcare Conference
February 21 2020 - 7:30AM
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative
medicine company focused on the development, manufacture, and
commercialization of product solutions for the Advanced Wound Care
and Surgical and Sports Medicine markets, today announced that
company management will attend in the 9th Annual SVB Leerink Global
Healthcare Conference at the Lotte New York Palace in New York, New
York and participate in a fireside chat on Wednesday, February 26
at 3:30 p.m. Eastern Time.
A live audio webcast of the conference presentation will be
accessible by visiting the “Upcoming Events” section on the
“Investor Relations” page of Organogenesis’s website
www.organogenesis.com. An archive of the webcast will be available
for replay following the conference for approximately 30 days.
About Organogenesis Holdings Inc. Organogenesis
Holdings Inc. is a leading regenerative medicine company offering a
portfolio of bioactive and acellular biomaterials products in
advanced wound care and surgical biologics, including orthopedics
and spine. Organogenesis’s comprehensive portfolio is designed to
treat a variety of patients with repair and regenerative needs. For
more information, visit www.organogenesis.com.
Investor Inquiries:
Westwicke Partners
Mike Piccinino, CFA
OrganoIR@westwicke.com
443-213-0500
Press and Media Inquiries:
Organogenesis
Marcus Girolamo
MGirolamo@organo.com
817-688-4767
Organogenesis (NASDAQ:ORGO)
Historical Stock Chart
From Apr 2024 to May 2024
Organogenesis (NASDAQ:ORGO)
Historical Stock Chart
From May 2023 to May 2024